Background: Blood-based biomarkers (BBMs) may facilitate early detection of Alzheimers disease (AD), yet data in Latino populations remain limited. We examined associations of plasma biomarkers with cognition and depressive symptoms in Spanish-speaking Latino older adults enrolled in the Boston Latino Aging Study (BLAS...
C. Tristão-Pereira, G. Silva, K. Lopez et al.· medRxiv· 0 citations
Objective: Limited normative data for Spanish-speaking older adults may limit equitable assessments and increase misdiagnosis risk. We developed norms in the Boston Latino Aging Study (BLAST), including the Mini Mental State Exam (MMSE), Oral Symbol Digit Modalities Test (OSDMT), WAIS-IV Matrix Reasoning, and Categor...
Daniel G. Saldana, L. Martínez, Nadeshka J. Ramirez et al.· Archives of Clinical Neurops...· 0 citations
It is revealed that mild behavioral impairment symptoms may emerge before cognitive decline in ADAD and supports the MBI‐C as a tool for detecting early behavioral changes linked to AD pathology and identifying at‐risk individuals for clinical trials and early intervention.
Catarina Tristão-Pereira, D. Vásquez, Jorge Alcina et al.· Alzheimer's & Dementia· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.